GlassScriptPhysician profile
Katelyn E Santoro
NPI 1669813770
$1,452.53
in general payments reported to CMS, 2019-2025
24 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.35 · 2022: $216 · 2023: $356 · 2024: $506 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.49 |
| Education | $159.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $302.48 | 2021-2023 | |
| Abbvie INC. | $129.92 | 2022-2025 | |
| Janssen Biotech, INC. | $120.40 | 2022-2024 | Erleada |
| Coloplast Corp | $118.24 | 2024 | |
| Hollister Incorporated | $83.81 | 2023-2024 | Vapro Pocket, Infyna Chic |
| Progenics Pharmaceuticals, INC. | $82.86 | 2023-2025 | Pylarify |
| Tolmar, INC. | $71.72 | 2024-2025 | Jatenzo, Eligard |
| Abc Home Medical Supply, INC. | $55.22 | 2024 | |
| Sumitomo Pharma America, INC. | $50.11 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $49.89 | 2023-2024 | Jelmyto |
| Photocure INC | $46.38 | 2023-2024 | Cysview |
| Urovant Sciences INC | $41.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.58 | 2022-2023 | |
| Immunitybio, INC. | $37.35 | 2025 | |
| 180 Medical, INC. | $34.63 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $32.92 | 2025 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $25.86 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Bluewind Medical | $22.70 | 2025 | |
| Merck Sharp & Dohme LLC | $20.15 | 2024 | Lynparza |
| Olympus America INC. | $19.61 | 2025 | Itind System |
| Pfizer INC. | $18.79 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.93 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $16.77 | 2024 | |
| Antares Pharma, INC. | $16.61 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Santoro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.